Elsevier

Brain Research

Volume 1380, 22 March 2011, Pages 42-77
Brain Research

Review
Etiological heterogeneity in autism spectrum disorders: More than 100 genetic and genomic disorders and still counting

https://doi.org/10.1016/j.brainres.2010.11.078Get rights and content

Abstract

There is increasing evidence that autism spectrum disorders (ASDs) can arise from rare highly penetrant mutations and genomic imbalances. The rare nature of these variants, and the often differing orbits of clinical and research geneticists, can make it difficult to fully appreciate the extent to which we have made progress in understanding the genetic etiology of autism. In fact, there is a persistent view in the autism research community that there are only a modest number of autism loci known. We carried out an exhaustive review of the clinical genetics and research genetics literature in an attempt to collate all genes and recurrent genomic imbalances that have been implicated in the etiology of ASD. We provide data on 103 disease genes and 44 genomic loci reported in subjects with ASD or autistic behavior. These genes and loci have all been causally implicated in intellectual disability, indicating that these two neurodevelopmental disorders share common genetic bases. A genetic overlap between ASD and epilepsy is also apparent in many cases. Taken together, these findings clearly show that autism is not a single clinical entity but a behavioral manifestation of tens or perhaps hundreds of genetic and genomic disorders. Increased recognition of the etiological heterogeneity of ASD will greatly expand the number of target genes for neurobiological investigations and thereby provide additional avenues for the development of pathway-based pharmacotherapy. Finally, the data provide strong support for high-resolution DNA microarrays as well as whole-exome and whole-genome sequencing as critical approaches for identifying the genetic causes of ASDs.

Research Highlights

► The genetic architecture of autism is like that of intellectual disability, with many genetic and genomic disorders involved, each accounting for a small fraction of cases. ► A review of the literature identified 103 disease genes and 44 genomic disorders reported in subjects with ASD or autistic behavior. ► These loci have all been implicated in intellectual disability, indicating shared molecular mechanisms.

Introduction

Autism is the most severe manifestation of a group of neurodevelopmental disabilities known as autism spectrum disorders (ASDs), which also include Asperger syndrome and pervasive developmental disorder not otherwise specified (PDD-NOS). ASDs are characterized by impaired social interaction and communication and by restricted interests and repetitive behaviors. Over 70% of individuals with autism have intellectual disability (ID), while epilepsy occurs in ~ 25% (Baird et al., 2006, Tuchman and Rapin, 2002). ASDs are identified in about 1% of children (Baird et al., 2006) and are four times more common in males than in females. There is a strong genetic basis to ASDs, as indicated by the recurrence risk in families, twin studies, and the co-occurrence with chromosomal disorders and rare genetic syndromes. The genetic architecture of ASDs is highly heterogeneous (Abrahams and Geschwind, 2008). About 10%–20% of individuals with an ASD have an identified genetic etiology. Microscopically visible chromosomal alterations have been reported in ∼ 5% of cases; the most frequent abnormalities are 15q11–q13 duplications, and 2q37, 22q11.2 and 22q13.3 deletions. ASDs can also be due to mutations of single genes involved in autosomal dominant, autosomal recessive and X-linked disorders. The most common single gene mutation in ASDs is fragile X syndrome (FMR1), present in ∼ 2% of cases. Other monogenic disorders described in ASD include tuberous sclerosis (TSC1, TSC2), neurofibromatosis (NF1), Angelman syndrome (UBE3A), Rett syndrome (MECP2) and PTEN mutations in patients with macrocephaly and autism. Rare mutations have been identified in synaptic genes, including NLGN3, NLGN4X (Jamain et al., 2003), SHANK3 (Durand et al., 2007), and SHANK2 (Berkel et al., 2010). Recent whole-genome microarray studies have revealed submicroscopic deletions and duplications, called copy number variation (CNV), affecting many loci and including de novo events in 5%–10% of ASD cases (Christian et al., 2008, Glessner et al., 2009, Marshall et al., 2008, Pinto et al., 2010, Sebat et al., 2007, Szatmari et al., 2007).

The accumulating number of distinct, individually rare genetic causes in ASD suggests that the genetic architecture of autism resembles that of ID, with many genetic and genomic disorders involved, each accounting for a small fraction of cases. In fact, all the known genetic causes of ASDs are also causes of ID, indicating that these two neurodevelopmental disorders share common genetic bases. An illustrative example is that of the X-linked neuroligin 4 (NLGN4X) gene, encoding a synaptic cell-adhesion protein. The first NLGN4X mutation was reported in a family with two brothers affected with ASD, one with autism and ID and the other with Asperger syndrome and normal intelligence (Jamain et al., 2003). Subsequently, a truncating mutation in NLGN4X was identified in a multi-generational pedigree with 13 affected males having either non-syndromic ID (10 individuals), ID with ASD (2 individuals) or ASD without ID (1 individual) (Laumonnier et al., 2004). This indicates that exploring ID genes in individuals with ASD can greatly expand the number of genes playing a causal role and identify additional molecular pathways.

Like ASDs, ID is a common and highly heterogeneous neurodevelopmental disorder, affecting 2%–3% of the population. About 25%–50% of ID is believed to be caused by genetic defects, and the large number of X-linked forms account in part for the 30% higher prevalence of ID in males compared to females (for recent reviews, see Ropers, 2010 and Gecz et al., 2009). Like in ASD, chromosomal abnormalities detected with conventional karyotyping account for about 5% of cases of ID, while novel molecular karyotyping methods have a diagnostic yield of 10%–15%. Again like in ASD, fragile X syndrome is the most common monogenic cause of ID. At least 50 genes have been identified that are associated with syndromic, or clinically distinctive, X-linked ID, and over 40 genes have been found to be associated with non-syndromic X-linked ID (Fig. 1). In addition, numerous autosomal genes, both dominant and recessive, have been linked to non-syndromic and syndromic ID. The distinction between syndromic and non-syndromic ID is not precise, and several genes, initially identified in syndromic conditions, were later reported in subjects with non-syndromic forms (e.g., ARX, CASK, JARID1C, FGD1 and ATRX).

Here, we review the different genetic and genomic disorders in which ASDs have been described as one of the possible manifestations. The findings indicate that, in contrast to a persisting claim that we know very little about the etiology of autism, there are more than 100, already identified, recurrent genetic defects than can cause ASD. All the genes and chromosomal rearrangements identified are well-known causes of ID, either syndromic or non-syndromic. Several have been involved in epilepsy, with or without ID, suggesting that this is another neurodevelopmental disorder that shares genetic risk factors with ASD. It is also of interest to see that the genes implicated in ASD go beyond those involved in synaptic function and affect a wide range of cellular processes.

Section snippets

Results

Table 1 presents a list of 103 known disease genes that have been reported to be mutated, deleted, duplicated, or disrupted by a translocation breakpoint in individuals with ASD or autistic features. Table 2 shows 44 recurrent genomic disorders and chromosomal aneuploidies reported in subjects with ASD/autistic traits. Only recurrent rearrangements were included. Fifteen genes from Table 1 are responsible for the phenotypic characteristics of microdeletion/microduplication syndromes listed in

Discussion

Our exhaustive review of the current literature identified more than 100 loci for which there is evidence for a causal role in ASDs. The majority have not been explored in ASD. Sequencing would be required to identify many of these mutations but to date only very targeted sequencing approaches have been performed in ASD research. There is every reason to believe that with whole-exome and whole-genome sequencing approaches mutations in these genes will be identified in additional cases, and many

Conclusion

The data presented in this review makes it abundantly clear that autism represents the final common pathway for numerous genetic brain disorders. Many well-recognized “ID genes” (which in fact do not cause ID in all affected individuals) can also cause ASD, with or without ID. Similarly, several genes initially identified in epilepsy samples can also result in ASD and ID. These findings indicate that these genes cause a continuum of neurodevelopmental disorders that manifest in different ways

Experimental procedures

An extensive literature search was conducted looking for articles describing genetic disorders in patients with autism, ASD, pervasive developmental disorder, Asperger syndrome, PDD-NOS, or autistic/autistic-like traits/features/behavior, using PubMed and Google Scholar, a well as follow-up of references cited in the papers thus identified. The genetic disorders considered all can have neurological manifestations, most commonly ID and/or epilepsy.

For disorders for which the association with ASD

Acknowledgments

I am deeply grateful to Mary Coleman for stimulating discussions about the role of medical disorders in the etiology of autism. I also thank Joseph Buxbaum for helpful comments on this manuscript, and Marion Pilorge for help with the figure.

References (379)

  • C. Depienne et al.

    Screening for genomic rearrangements and methylation abnormalities of the 15q11–q13 region in autism spectrum disorders

    Biol. Psychiatry

    (2009)
  • B.S. Abrahams et al.

    Advances in autism genetics: on the threshold of a new neurobiology

    Nat. Rev. Genet.

    (2008)
  • M.T. Abrams et al.

    Cognitive, behavioral, and neuroanatomical assessment of two unrelated male children expressing FRAXE

    Am. J. Med. Genet.

    (1997)
  • AddingtonA.M. et al.

    A novel frameshift mutation in UPF3B identified in brothers affected with childhood onset schizophrenia and autism spectrum disorders

    Mol. Psychiatry

    (2010)
  • A. Adegbola et al.

    A novel mutation in JARID1C/SMCX in a patient with autism spectrum disorder (ASD)

    Am. J. Med. Genet. A

    (2008)
  • S. Alliman et al.

    Clinical and molecular characterization of individuals with recurrent genomic disorder at 10q22.3q23.2

    Clin. Genet.

    (2010)
  • Al-OwainM. et al.

    Novel intragenic deletion in OPHN1 in a family causing XLMR with cerebellar hypoplasia and distinctive facial appearance

    Clin. Genet.

    (2010)
  • B.M. Anderlid et al.

    Subtelomeric rearrangements detected in patients with idiopathic mental retardation

    Am. J. Med. Genet.

    (2002)
  • K.M. Antshel et al.

    Autistic spectrum disorders in velo-cardio facial syndrome (22q11.2 deletion)

    J. Autism Dev. Disord.

    (2007)
  • H.L. Archer et al.

    CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients

    J. Med. Genet.

    (2006)
  • F. Assumpcao et al.

    Brief report: autism and Aarskog syndrome

    J. Autism Dev. Disord.

    (1999)
  • M. Aziz et al.

    Clinical features of boys with fragile X premutations and intermediate alleles

    Am. J. Med. Genet. B Neuropsychiatr. Genet.

    (2003)
  • S. Baieli et al.

    Autism and phenylketonuria

    J. Autism Dev. Disord.

    (2003)
  • B.C. Ballif et al.

    Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication

    Mol. Cytogenet.

    (2008)
  • H.N. Baris et al.

    Diagnostic utility of array-based comparative genomic hybridization in a clinical setting

    Am. J. Med. Genet. A

    (2007)
  • S. Barnett et al.

    Behavioural phenotype of Bardet–Biedl syndrome

    J. Med. Genet.

    (2002)
  • A.J. Barnicoat et al.

    Clinical, cytogenetic, and molecular analysis of three families with FRAXE

    J. Med. Genet.

    (1997)
  • E. Basile et al.

    The behavioural phenotype of Cornelia de Lange Syndrome: a study of 56 individuals

    J. Intellect. Disabil. Res.

    (2007)
  • A. Battaglia et al.

    Etiologic yield of autistic spectrum disorders: a prospective study

    Am. J. Med. Genet. C Semin. Med. Genet.

    (2006)
  • G. Baynam et al.

    A case of 3q29 microdeletion with novel features and a review of cytogenetically visible terminal 3q deletions

    Clin. Dysmorphol.

    (2006)
  • C.L. Bennett et al.

    Prevalence of ALDH7A1 mutations in 18 North American pyridoxine-dependent seizure (PDS) patients

    Epilepsia

    (2009)
  • S. Ben-Shachar et al.

    Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders

    J. Med. Genet.

    (2009)
  • S. Berkel et al.

    Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation

    Nat. Genet.

    (2010)
  • S. Berland et al.

    Late-onset gain of skills and peculiar jugular pit in an 11-year-old girl with 5q14.3 microdeletion including MEF2C

    Clin. Dysmorphol.

    (2010)
  • J. Bernaciak et al.

    Clinical and molecular-cytogenetic evaluation of a family with partial Jacobsen syndrome without thrombocytopenia caused by an approximately 5 Mb deletion del(11)(q24.3)

    Am. J. Med. Genet. A

    (2008)
  • T.P. Berney et al.

    Behavioural phenotype of Cornelia de Lange syndrome

    Arch. Dis. Child.

    (1999)
  • BetancurC. et al.

    Etiological heterogeneity in autism: implications for linkage and association studies

  • BetancurC. et al.

    Chromosome 17q21.31 microdeletion in a patient with autism

  • S.S. Bhat et al.

    Disruption of the IL1RAPL1 gene associated with a pericentromeric inversion of the X chromosome in a patient with mental retardation and autism

    Clin. Genet.

    (2008)
  • Z.A. Bhuiyan et al.

    Genotype–phenotype correlations of 39 patients with Cornelia De Lange syndrome: the Dutch experience

    J. Med. Genet.

    (2006)
  • W. Bi et al.

    Increased LIS1 expression affects human and mouse brain development

    Nat. Genet.

    (2009)
  • BishopD.V. et al.

    Autism, language and communication in children with sex chromosome trisomies

    Arch. Dis. Child.

    (2010)
  • A. Bizzi et al.

    X-linked creatine deficiency syndrome: a novel mutation in creatine transporter gene SLC6A8

    Ann. Neurol.

    (2002)
  • E. Blennow et al.

    Monosomy 1p36.31–33–>pter due to a paternal reciprocal translocation: prognostic significance of FISH analysis

    Am. J. Med. Genet.

    (1996)
  • T.A. Blondis et al.

    Asperger syndrome associated with Steinert's myotonic dystrophy

    Dev. Med. Child Neurol.

    (1996)
  • P.F. Bolton et al.

    Chromosome 15q11–13 abnormalities and other medical conditions in individuals with autism spectrum disorders

    Psychiatr. Genet.

    (2004)
  • M.T. Bonati et al.

    Evaluation of autism traits in Angelman syndrome: a resource to unfold autism genes

    Neurogenetics

    (2007)
  • C. Bonnet et al.

    Microdeletion at chromosome 4q21 defines a new emerging syndrome with marked growth restriction, mental retardation and absent or severely delayed speech

    J. Med. Genet.

    (2010)
  • G. Borck et al.

    Clinical, cellular, and neuropathological consequences of AP1S2 mutations: further delineation of a recognizable X-linked mental retardation syndrome

    Hum. Mutat.

    (2008)
  • T.M. Bosley et al.

    Clinical characterization of the HOXA1 syndrome BSAS variant

    Neurology

    (2007)
  • Cited by (0)

    View full text